Jonathan R Dillman1, Ethan A Smith2, Ramon Sanchez2, Michael A DiPietro2, Soudabeh Fazeli Dehkordy2, Jeremy Adler3, Vera DeMatos-Maillard3, Shokoufeh Khalatbari4, Matthew S Davenport5. 1. Department of Radiology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., Cincinnati, OH, 45229-3039, USA. jonathan.dillman@cchmc.org. 2. Department of Radiology, Section of Pediatric Radiology, University of Michigan Health System, C.S. Mott Children's Hospital, Ann Arbor, MI, USA. 3. Department of Pediatrics, Division of Pediatric Gastroenterology, University of Michigan Health System, C.S. Mott Children's Hospital, Ann Arbor, MI, USA. 4. Michigan Institute for Clinical and Health Research, University of Michigan, Ann Arbor, MI, USA. 5. Department of Radiology, Division of Abdominal Imaging, University of Michigan Health System, University of Michigan Hospital, Ann Arbor, MI, USA.
Abstract
BACKGROUND: There is a paucity of published literature describing ultrasound (US)-US and US-MR enterography (MRE) inter-radiologist agreement in pediatric small bowel Crohn disease. OBJECTIVE: To prospectively assess US-US and US-MRE inter-radiologist agreement in pediatric small bowel Crohn disease. MATERIALS AND METHODS: Institutional Review Board approval and informed consent/assent were obtained for this HIPAA-compliant prospective cohort study of children with newly diagnosed distal small bowel Crohn disease (July 2012 to December 2014). Enrolled subjects (n = 29) underwent two small bowel US examinations performed by blinded independent radiologists both before and at multiple time points after initiation of medical therapy (231 unique US examinations, in total); 134 US examinations were associated with concurrent MRE. The MRE examination was interpreted by a third blinded radiologist. The following was documented on each examination: involved length of ileum (cm); maximum bowel wall thickness (mm); amount of bowel wall and mesenteric Doppler signal, and presence of stricture, penetrating disease and/or abscess. Inter-radiologist agreement was assessed with single-measure, three-way, mixed-model intra-class correlation coefficients (ICC) and prevalence-adjusted, bias-adjusted kappa statistics (κ). Numbers in brackets are 95% confidence intervals. RESULTS: Ultrasound-US agreement was moderate for involved length (ICC: 0.41 [0.35-0.49]); substantial for maximum bowel wall thickness (ICC: 0.67 [0.64-0.70]); moderate for bowel wall Doppler signal (ICC: 0.53 [0.48-0.59]); slight for mesenteric Doppler signal (ICC: 0.25 [0.18-0.42]), and moderate to almost perfect for stricture (κ: 0.54), penetrating disease (κ: 0.80), and abscess (κ: 0.96). US-MRE agreement was moderate for involved length (ICC: 0.42 [0.37-0.49]); substantial for maximum bowel wall thickness (ICC: 0.66 [0.65-0.69]), and substantial to almost perfect for stricture (κ: 0.61), penetrating disease (κ: 0.72) and abscess (κ: 0.88). CONCLUSION: Ultrasound-US agreement was similar to US-MRE agreement for assessing pediatric small bowel Crohn disease. Discrepancies in US-US and US-MRE reporting question the utility of US as an accurate, reproducible radiologic biomarker for assessing response to medical therapy and disease-related complications.
BACKGROUND: There is a paucity of published literature describing ultrasound (US)-US and US-MR enterography (MRE) inter-radiologist agreement in pediatric small bowel Crohn disease. OBJECTIVE: To prospectively assess US-US and US-MRE inter-radiologist agreement in pediatric small bowel Crohn disease. MATERIALS AND METHODS: Institutional Review Board approval and informed consent/assent were obtained for this HIPAA-compliant prospective cohort study of children with newly diagnosed distal small bowel Crohn disease (July 2012 to December 2014). Enrolled subjects (n = 29) underwent two small bowel US examinations performed by blinded independent radiologists both before and at multiple time points after initiation of medical therapy (231 unique US examinations, in total); 134 US examinations were associated with concurrent MRE. The MRE examination was interpreted by a third blinded radiologist. The following was documented on each examination: involved length of ileum (cm); maximum bowel wall thickness (mm); amount of bowel wall and mesenteric Doppler signal, and presence of stricture, penetrating disease and/or abscess. Inter-radiologist agreement was assessed with single-measure, three-way, mixed-model intra-class correlation coefficients (ICC) and prevalence-adjusted, bias-adjusted kappa statistics (κ). Numbers in brackets are 95% confidence intervals. RESULTS: Ultrasound-US agreement was moderate for involved length (ICC: 0.41 [0.35-0.49]); substantial for maximum bowel wall thickness (ICC: 0.67 [0.64-0.70]); moderate for bowel wall Doppler signal (ICC: 0.53 [0.48-0.59]); slight for mesenteric Doppler signal (ICC: 0.25 [0.18-0.42]), and moderate to almost perfect for stricture (κ: 0.54), penetrating disease (κ: 0.80), and abscess (κ: 0.96). US-MRE agreement was moderate for involved length (ICC: 0.42 [0.37-0.49]); substantial for maximum bowel wall thickness (ICC: 0.66 [0.65-0.69]), and substantial to almost perfect for stricture (κ: 0.61), penetrating disease (κ: 0.72) and abscess (κ: 0.88). CONCLUSION: Ultrasound-US agreement was similar to US-MRE agreement for assessing pediatric small bowel Crohn disease. Discrepancies in US-US and US-MRE reporting question the utility of US as an accurate, reproducible radiologic biomarker for assessing response to medical therapy and disease-related complications.
Authors: M Fraquelli; A Sarno; C Girelli; C Laudi; E Buscarini; C Villa; D Robotti; P Porta; T Cammarota; E Ercole; C Rigazio; C Senore; A Pera; V Malacrida; C Gallo; G Maconi Journal: Dig Liver Dis Date: 2008-06-25 Impact factor: 4.088
Authors: Daniel T Barkmeier; Jonathan R Dillman; Mahmoud Al-Hawary; Amer Heider; Matthew S Davenport; Ethan A Smith; Jeremy Adler Journal: Pediatr Radiol Date: 2015-12-05
Authors: Alexander J Towbin; John Sullivan; Lee A Denson; Daniel B Wallihan; Daniel J Podberesky Journal: Radiographics Date: 2013 Nov-Dec Impact factor: 5.333
Authors: Timothy L Tsai; Megan B Marine; Matthew R Wanner; Matthew L Cooper; Steven J Steiner; Fangqian Ouyang; S Gregory Jennings; Boaz Karmazyn Journal: Pediatr Radiol Date: 2017-04-22
Authors: Daniel G Rosenbaum; Maire A Conrad; David M Biko; Eduardo D Ruchelli; Judith R Kelsen; Sudha A Anupindi Journal: Pediatr Radiol Date: 2016-09-29
Authors: Jonathan R Dillman; Soudabeh Fazeli Dehkordy; Ethan A Smith; Michael A DiPietro; Ramon Sanchez; Vera DeMatos-Maillard; Jeremy Adler; Bin Zhang; Andrew T Trout Journal: Pediatr Radiol Date: 2017-04-18
Authors: Elsa A van Wassenaer; Floris A E de Voogd; Rick R van Rijn; Johanna H van Der Lee; Merit M Tabbers; Faridi S van Etten-Jamaludin; Krisztina B Gecse; Angelika Kindermann; Tim G J De Meij; Geert R D'haens; Marc A Benninga; Bart G P Koot Journal: J Crohns Colitis Date: 2019-12-10 Impact factor: 9.071
Authors: Elsa A van Wassenaer; Marc A Benninga; Johan L van Limbergen; Geert R D'Haens; Anne M Griffiths; Bart G P Koot Journal: Inflamm Bowel Dis Date: 2022-05-04 Impact factor: 5.325